Was your child born with cleft palate or another defect after you took
Zofran for nausea?
Recent lawsuits allege that prenatal exposure to the anti-nausea drug Zofran
(ondansetron) causes serious birth defects such as cleft palate. The U.S.
Food and Drug Administration initially approved use of the prescription
drug Zofran to treat cancer patients suffering from nausea after chemotherapy,
surgery, and other treatments.
GlaxoSmithKline, the drug's manufacturer, then began marketing the
drug to pregnant women to combat morning sickness
even though the FDA never approved Zofran for this use. GlaxoSmithKline agreed to a $3 billion payout back in 2012 to settle
federal charges claiming the company had illegally promoted Zofran and
GlaxoSmithKline is now facing a new wave of allegations concerning Zofran,
including the claim that accuses the drug manufacturer of knowing the
risk of harm Zofran could cause to developing babies yet marketing the
drug to pregnant women anyway.
Current Zofran Birth Injury Lawsuits
There have been multiple lawsuits within recent months against Zofran's
- A case filed April 1, 2015 in the U.S. District Court, Northern District
of Alabama (Case 2:15-cv-00544-JEO) alleges that Zofran was the cause
of various birth defects.
- A case filed April 3, 2015 in the U.S. District Court, District of Montana
(1:15-cv-00026-SPW-CSO) claims that Zofran use in a mother's first
trimester caused a baby to be born with a cleft palate.
Birth defect cases such as this are complicated, costly, and life shattering.
Domina Law Group approaches these types of cases with a commitment to
understand what went wrong and to secure justice for the child and their family.
Call Our Nebraska Birth Injury Attorneys
Domina Law Group is currently investigating claims linking prenatal Zofran
birth defects. If you took Zofran during your pregnancy and your child was born with
cleft palate or another type of birth defect, we invite you to contact
us today to assess your case.
Zofran Lawsuit News